These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 26145249)

  • 81. Application of "Omics" Technologies for Diagnosis and Pathogenesis of Neurological Infections.
    Noorbakhsh F; Aminian A; Power C
    Curr Neurol Neurosci Rep; 2015 Sep; 15(9):58. PubMed ID: 26198887
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Advances in the Study of Metabolomics and Metabolites in Some Species Interactions.
    Liu R; Bao ZX; Zhao PJ; Li GH
    Molecules; 2021 May; 26(11):. PubMed ID: 34072976
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Maternal sepsis in the era of genomic medicine.
    Kouskouti C; Evangelatos N; Brand A; Kainer F
    Arch Gynecol Obstet; 2018 Jan; 297(1):49-60. PubMed ID: 29103195
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Post-genomics nanotechnology is gaining momentum: nanoproteomics and applications in life sciences.
    Kobeissy FH; Gulbakan B; Alawieh A; Karam P; Zhang Z; Guingab-Cagmat JD; Mondello S; Tan W; Anagli J; Wang K
    OMICS; 2014 Feb; 18(2):111-31. PubMed ID: 24410486
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [OMICS and biomarkers of glial tumors].
    Idbaih A
    Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Gastroenterological Cancer Diagnosis by Metabolomics-Discovery of Pancreatic Cancer Biomarker].
    Yoshida M; Nishiumi S; Azuma T
    Rinsho Byori; 2015 Apr; 63(4):450-6. PubMed ID: 26536778
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Utilization of Analytical Omics Tools in the Molecular Diagnostics of Multiple Myeloma.
    Kovacs Z; Guttman A
    Curr Mol Med; 2018; 18(4):260-272. PubMed ID: 30295190
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The role of metabolomic markers for patients with infectious diseases: implications for risk stratification and therapeutic modulation.
    Zurfluh S; Baumgartner T; Meier MA; Ottiger M; Voegeli A; Bernasconi L; Neyer P; Mueller B; Schuetz P
    Expert Rev Anti Infect Ther; 2018 Feb; 16(2):133-142. PubMed ID: 29316826
    [TBL] [Abstract][Full Text] [Related]  

  • 89. 18O-assisted dynamic metabolomics for individualized diagnostics and treatment of human diseases.
    Nemutlu E; Zhang S; Juranic NO; Terzic A; Macura S; Dzeja P
    Croat Med J; 2012 Dec; 53(6):529-34. PubMed ID: 23275318
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Exploring disease through metabolomics.
    Vinayavekhin N; Homan EA; Saghatelian A
    ACS Chem Biol; 2010 Jan; 5(1):91-103. PubMed ID: 20020774
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Application of metabolomics to diagnosis of insulin resistance.
    Milburn MV; Lawton KA
    Annu Rev Med; 2013; 64():291-305. PubMed ID: 23327524
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric Disorders.
    Sethi S; Brietzke E
    Int J Neuropsychopharmacol; 2015 Oct; 19(3):pyv096. PubMed ID: 26453695
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The Increasing Impact of Translational Research in the Molecular Diagnostics of Neuromuscular Diseases.
    Yubero D; Natera-de Benito D; Pijuan J; Armstrong J; Martorell L; Fernàndez G; Maynou J; Jou C; Roldan M; Ortez C; Nascimento A; Hoenicka J; Palau F
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924139
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pathogen genomics leading to vaccines.
    Nat Genet; 2019 Jun; 51(6):923. PubMed ID: 31152162
    [No Abstract]   [Full Text] [Related]  

  • 95. The Evolving Role of Companion Diagnostics for Breast Cancer in an Era of Next-Generation Omics.
    Rosenbaum JN; Weisman P
    Am J Pathol; 2017 Oct; 187(10):2185-2198. PubMed ID: 28733195
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Host-microbe interactions: Profiles in the transcriptome, the proteome, and the metabolome.
    Nguyen T; Sedghi L; Ganther S; Malone E; Kamarajan P; Kapila YL
    Periodontol 2000; 2020 Feb; 82(1):115-128. PubMed ID: 31850641
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Integrative genomics important to understand host-pathogen interactions.
    Mehta P; Swaminathan A; Yadav A; Chattopadhyay P; Shamim U; Pandey R
    Brief Funct Genomics; 2024 Jan; 23(1):1-14. PubMed ID: 35909219
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Postgenomic Medicine: Alternative to Biomarkers].
    Lisitsa AV; Ponomarenko EA; Lokhov PG; Archakov AI
    Vestn Ross Akad Med Nauk; 2016; 71(3):255-60. PubMed ID: 29297642
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Host genetic regulation of immune-based and infectious diseases : Introduction to mammalian genome special issue: genetics of infectious disease.
    Ferris MT; Hood DW
    Mamm Genome; 2018 Aug; 29(7-8):365-366. PubMed ID: 30171339
    [No Abstract]   [Full Text] [Related]  

  • 100. [Biotechnological advances in infectious diseases diagnosis].
    Hernández-Hernández Fde L; Rodríguez MH
    Salud Publica Mex; 2009; 51 Suppl 3():S424-38. PubMed ID: 20464216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.